Medical/Pharmaceuticals
Significant Case Intake Efficiencies Found in Newly Launched Life Sciences Generative AI Solution
Advanced Intake™ demonstrates up to 65% efficiency gains in adverse case intake and 90% data extraction accuracy and quality BOSTON, April 23, 2024 /PRNewswire/ -- ArisGlobal, an innovative life sciences technology company and creator of LifeSphere®, today revealed details about itsAdvanced Inta...
2024-04-23 20:00
612
Zayed Sustainability Prize's Beyond2020 Initiative Deploys Life-saving Digital Mammograms in Costa Rica
AI-powered mammography services will help detect breast cancer cases among women living in underprivileged communities acrossCosta Rica ABU DHABI, UAE, April 23, 2024 /PRNewswire/ -- Beyond2020, the flagship initiative launched by the Zayed Sustainability Prize, the UAE's pioneering award for su...
2024-04-23 18:39
675
OSR Holdings and SillaJen have entered into a Memorandum of Understanding to collaboratively pursue the development of innovative therapeutics and enter the U.S. market
SEOUL, South Korea, April 23, 2024 /PRNewswire/ -- OSR Holdings, a global healthcare holding company, announced that it has signed a memorandum of understanding (MOU) with SillaJen, a Kosdaq-listed biotech firm with a pipeline of immuno-oncology drug candidates, to share technology and clinical ...
2024-04-23 18:37
1033
Smartee Showcases Mandibular Repositioning Technology at IDEM Singapore 2024
SINGAPORE, April 23, 2024 /PRNewswire/ -- Smartee Denti-Technology, a global leader in digital orthodontic solutions, proudly announces its successful participation in the International Dental Exhibition and Meeting (IDEM) 2024, held fromApril 19 to April 21 at Marina Bay Sands, Singapore. &...
2024-04-23 16:51
773
Borsch Med Introduces Chondroitin Supplements to Singapore for Healthy Joints
Chondroitin-based supplements from Zeria Pharmaceutical launched to promote an active lifestyle SINGAPORE, April 23, 2024 /PRNewswire/ -- Borsch Med Pte Ltd (BM), a leading Traditional Chinese Medicine (TCM), Health and Nutrition company based in Singapore, operated and managed by professionals i...
2024-04-23 15:00
740
HanxBio announces the publication of a research paper in Scientific Reports on preclinical evaluation of Narazaciclib for the treatment of acute myeloid leukemia (AML)
SAN DIEGO and WUHAN, China, April 23, 2024 /PRNewswire/ -- HanxBio today announced that it has published a research article titled "Narazaciclib, a novel multikinase inhibitor with potent activity against CSF1R, FLT3 and CDK6, shows strong anti-AML activity in defined preclinical models" in the N...
2024-04-23 14:54
740
VERTEX AND TREEFROG THERAPEUTICS ANNOUNCE LICENSING AGREEMENT AND COLLABORATION TO OPTIMIZE PRODUCTION OF VERTEX'S CELL THERAPIES FOR TYPE 1 DIABETES
* Vertex obtains an exclusive license to TreeFrog's C-StemTM manufacturing technology in type 1 diabetes * TreeFrog and Vertex to collaborate on scale-up of fully differentiated, insulin-producing pancreatic islet cells BOSTON and BORDEAUX, France, April 23, 2024 /PRNewswire/ -- Vertex Pha...
2024-04-23 12:45
856
Virtus Fertility Centre Singapore sets up a ReadyBaby Fertility Grant for those facing financial and family planning challenges
This grant is designed to support eligible Singaporean couples in achieving their dream of having a baby, offering them a chance at pregnancy in a private setting. SINGAPORE, April 23, 2024 /PRNewswire/ -- To help married Singaporean couples facing infertility and aspiring to start a family, Vir...
2024-04-23 10:59
832
Brise Pharmaceuticals Raises nearly $20M in Series Pre-A and Pre-A+ Financing
SHANGHAI, April 22, 2024 /PRNewswire/ -- Brise Pharmaceuticals Co., LTD. (Brise), a pioneering company specializing in innovative treatments for acute and chronic pain, has recently completed Pre-A and Pre-A+ financing with a total of approximately$20 million. This Pre-A round is led by Shunxi F...
2024-04-23 08:00
744
PharmAbcine's U.S. Subsidiary, Wincal Biopharm, to Present Preclinical Data from its Proprietary OPC Platform Targeting Ocular Diseases at the upcoming Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting 2024
* Preclinical data from the next generation eyedrop platform to be unveiled for the first time at ARVO 2024 DAEJEON, South Korea, April 22, 2024 /PRNewswire/ -- PharmAbcine, Inc. ("PharmAbcine" or the "Company") (KOSDAQ: 208340), a clinical-stage public company developing next generation therap...
2024-04-23 07:25
1036
TraceLink Named Finalist in the Prestigious Business Transformation & Operational Excellence Awards 2024
BOSTON, April 23, 2024 /PRNewswire/ -- TraceLink, a global leader in integrated digital supply network solutions, is proud to announce its recognition as a finalist in the esteemed Business Transformation & Operational Excellence Awards 2024. This recognition underscores TraceLink's commitment to...
2024-04-23 04:25
938
Datasea Inc. (NASDAQ: DTSS) and iPower Inc. (NASDAQ: IPW) Collaborate to Expand Product Distribution in US Online Markets
BEIJING, April 22, 2024 /PRNewswire/ -- Datasea Inc. (Nasdaq: DTSS) ("Datasea" or the "Company"), a trailblazing digital technology company incorporated in Nevada, dedicated to innovative solutions in acoustic high tech and 5G-Artificial Intelligence ("AI") multimodal communication technology inth...
2024-04-22 22:00
826
Enrolment completed in Actinogen's XanaCIDD phase 2a cognition & depression trial
Trial results anticipated in early Q3 this year SYDNEY, April 22, 2024 /PRNewswire/ -- Actinogen Medical Limited (ASX: ACW) announces the full enrolment of 167 participants in the Company's XanaCIDD phase 2a clinical trial in patients with cognitive impairment in major depressive disorder (MDD)....
2024-04-22 20:30
673
Waters Accelerates the Development of Gene-based Therapeutics with New GTxResolve Premier SEC Columns
News Summary: * New line of GTxResolve™ Premier SEC Columns provide higher sensitivity, resolution, and throughput to accelerate the development of cell & gene-based therapeutics. * Reduces problematic non-specific binding, minimizes mobile phase method development challenges, and provides h...
2024-04-22 20:00
829
Innovative Aspiration Thrombectomy System by Expanse ICE Receives FDA Clearance for vessels of the peripheral arterial and venous systems
PLEASANTON, Calif., April 22, 2024 /PRNewswire/ -- Expanse ICE announced today the ICE Aspiration System has received 510(k) clearance from the U.S. Food and Drug Administration. This announcement introduces a new and exciting player in the peripheral thrombectomy market. The ICE System is spec...
2024-04-22 20:00
818
Landmark New Publication: the Forgotten Biochemistry 101 of COVID-19
Legacy coronavirus biochemistry was overlooked that governs spike protein toxicity, key morbidities, risk factors and therapeutic responses SALT LAKE CITY, April 22, 2024 /PRNewswire/ -- TrialSite News features a paper published today in Viruses (Basel), authored by an international team of resea...
2024-04-22 19:52
813
Leo Cancer Care Teams up With World-Leading Carbon Ion Centre
Partnership will see Upright Radiotherapy System Installed at World-Leading Cancer Centre MIDDLETON, Wis., April 22, 2024 /PRNewswire/ -- Leo Cancer Care's unique upright radiotherapy solution is set to be installed in one of the world's most advanced oncology centres to deliver proton and carbo...
2024-04-22 18:43
923
Hyundai Bioscience announces its successful result from a preclinical study of a Niclosamide-based oral anticancer drug to treat triple-negative breast cancer
* Clinical trials of Niclosamide-based oral metabolic anticancer drug to commence for patients with difficult-to-treat cancers such as triple-negative breast cancer and pancreatic cancer * Niclosamide-based oral anticancer drug project to be carried out by the new subsidiary of Hyundai Biosci...
2024-04-22 17:51
836
Earth Day 2024: Angel Yeast Continues to Tackle Plastic Pollution Challenges With Bio-based Material Solutions
SHANGHAI, April 22, 2024 /PRNewswire/ -- Themed "Planet vs. Plastics," the 55th
Earth Day serves as a deep reminder for everyone to play a role in
environmental protection.Angel Yeast
2024-04-22 16:00
2273
GT20029 China Phase II Trial For AGA Reached Primary Endpoint
SUZHOU, China, April 21, 2024 /PRNewswire/ -- Kintor Pharmaceutical Limited ("Kintor Pharma", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and biological therapeutics, announced thatthe China phase II clinical trial (the "Phase II Clinical Trial") of i...
2024-04-22 09:53
1341
Week's Top Stories
Most Reposted
Earth Day 2024: Angel Yeast Continues to Tackle Plastic Pollution Challenges With Bio-based Material Solutions
[Picked up by 290 media titles]
2024-04-22 16:00
Trina Solar and PetroGreen Partner to Accelerate Philippine Solar Adoption with 117MW Supply Agreement
[Picked up by 289 media titles]
2024-04-22 06:00
With unique features, Hainan TV opened "The World's Specialty" pavilion at the Expo!
[Picked up by 287 media titles]
2024-04-18 21:26
China's Yiwu Establishes Welcoming Committee to Attract International Buyers
[Picked up by 286 media titles]
2024-04-19 13:25
Animated Life in Yunnan
[Picked up by 281 media titles]
2024-04-18 14:00
Most Read
With unique features, Hainan TV opened "The World's Specialty" pavilion at the Expo!
2024-04-18 21:26
8102
Combining Sustainability and Cybersecurity: Century Iron & Steel and Century Wind Power Both Receive ISO 27001 Information Security Certification
2024-04-19 18:03
8049
Animated Life in Yunnan
2024-04-18 14:00
7784
China's Yiwu Establishes Welcoming Committee to Attract International Buyers
2024-04-19 13:25
6465
IQAX eBL Wins Prestigious APTFF Trade Facilitation Innovation Award 2024
2024-04-18 10:36
3871